↓ Skip to main content

Is There a European View on Health Economic Evaluations? Results from a Synopsis of Methodological Guidelines Used in the EUnetHTA Partner Countries

Overview of attention for article published in PharmacoEconomics, October 2015
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter
8 X users

Citations

dimensions_citation
71 Dimensions

Readers on

mendeley
77 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Is There a European View on Health Economic Evaluations? Results from a Synopsis of Methodological Guidelines Used in the EUnetHTA Partner Countries
Published in
PharmacoEconomics, October 2015
DOI 10.1007/s40273-015-0328-1
Pubmed ID
Authors

EUnetHTA Joint Action 2, Work Package 7, Subgroup 3, Emelie Heintz, Andreas Gerber-Grote, Salah Ghabri, Francoise F. Hamers, Valentina Prevolnik Rupel, Renata Slabe-Erker, Thomas Davidson

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 77 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 77 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 14 18%
Researcher 11 14%
Other 9 12%
Student > Ph. D. Student 9 12%
Student > Bachelor 5 6%
Other 7 9%
Unknown 22 29%
Readers by discipline Count As %
Medicine and Dentistry 16 21%
Pharmacology, Toxicology and Pharmaceutical Science 12 16%
Economics, Econometrics and Finance 9 12%
Psychology 4 5%
Social Sciences 2 3%
Other 9 12%
Unknown 25 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 January 2016.
All research outputs
#6,981,937
of 26,017,215 outputs
Outputs from PharmacoEconomics
#797
of 2,008 outputs
Outputs of similar age
#77,100
of 293,486 outputs
Outputs of similar age from PharmacoEconomics
#9
of 22 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one has received more attention than most of these and is in the 72nd percentile.
So far Altmetric has tracked 2,008 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.7. This one has gotten more attention than average, scoring higher than 59% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 293,486 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 22 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.